Skip to content

revogene™ 130840

by Genepoc, Inc.

revogene 130840 is a medical device (FDA Class II; FDA product code OOI, Real Time Nucleic Acid Amplification System) made by Genepoc, Inc., cleared under FDA 510(k) K170558 on 25 May 2017 and listed in FDA GUDID since 29 Dec 2017 (UDI-DI 00628055344001), active as of 23 Oct 2026. 2 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

510(k) K170558

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00628055344001 UDI-DI Date29 Dec 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK170558 Date25 May 2017DecidedStatusActive

Official records

From the FDA record

Device description
The revogene™ instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. The revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real-time PCR.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K170558 decided 25 May 2017 Active
  • FDA GUDID UDI-DI 00628055344001 listed 29 Dec 2017 Listed

Recalls

2 recalls · 2 ongoing · FDA

    • Ongoing Z-1479-2022 FDA Class II initiated 22 Jun 2022

    When a run is aborted, the cooling period protection does not occur and the user is able to open the lid prior to the completion of the cooling period, exposing the user to heated instrument components. Incidental contact with heated instrument components may result in an injury such as minor burns.

    • Ongoing Z-0836-2022 FDA Class II initiated 15 Feb 2022

    The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.

Timeline

4 dated events

  1. Cleared FDA 510(k) K170558
  2. Listed FDA GUDID 00628055344001
  3. Recall initiated FDA recalls Z-0836-2022
  4. Recall initiated FDA recalls Z-1479-2022

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
revogene™
Generic name
Thermal cycler nucleic acid amplification analyser IVD, laboratory
Model / Ref / Catalog
130840
Primary DI / UDI-DI
00628055344001
510(k) Number
FDA product code
OOI
GMDN term
Thermal cycler nucleic acid amplification analyser IVD, laboratory
Device class
Class II
Regulation number
862.2570
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Thermal cycler nucleic acid amplification analyser IVD, laboratory.

Other devices from Genepoc, Inc.

  • GenePOC CDiff Open recall

    Class II
  • GenePOC Carba

    Class II
  • revogene Open recall

    Class II
  • GenePOC GBS LB

    Class I

See all devices from Genepoc, Inc. →

Properties

  • Prescription use
  • Serial number
Other properties (13, all answered No)